Hello again, dear readers, and welcome to a bonus letters column. This comes to you courtesy of the abundance of mail we have been receiving. We recently heard from a reader in Southern California who ...

Type 1 diabetes (T1D), which once predominantly ... that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...

Type 1 diabetes represents approximately 5-10% ... Modern management options include: Multiple daily injections using insulin pens or syringes Insulin pump therapy delivering programmed amounts ...

But adding type 1 diabetes ... However, advances in diabetes technology give people with the condition and their caregivers a little more freedom in their daily lives, helping reduce the constant ...

Netherlands: A new study published in Diabetes, Obesity and Metabolism highlights the long-term benefits of intermittently ...

But the clinical trials of these medications specifically excluded people with type 1 diabetes, who are dependent on the hormone insulin to survive because they can’t make enough of their own.

or a chain of amino acids—known as the B chain of insulin, or B:9-23—that is targeted by the immune cells in type 1 diabetes patients and identified mimics of this region in different microbes.The ...